Biocom California
@BiocomCA
Followers
8K
Following
7K
Media
4K
Statuses
9K
We are California’s leading advocate for life sciences.
California
Joined July 2009
🧬 CDR3 Therapeutics develops stem cell gene immunotherapies. 🔬Celltheon Corporation accelerates biotherapeutic development from early-stage research to manufacturing. ✨Embrient Life Sciences provides tools that enable controlled, reproducible cell culture.
0
0
0
It's #NewMemberMonday! 👩🔬 @AvanceCRO specializes in early-phase clinical trials for global biotech companies. 🎯 @BoundTherapy uses cancer cell–specific ASOs to target triple-negative breast cancer. 🔍 Axoiya creates SH2 “superbinders” to reveal deeper cell-signaling changes.
1
0
0
Join us in South San Francisco on April 23 for our 3rd annual Converge Summit, an executive-level conference dedicated to advancing human health through life science and technology collaboration. Spots are limited, apply to attend today: https://t.co/URHvs2v4hd
#ConvergeSummit
0
0
0
We are pleased to announce an MOU with @BioindustryPark Silvano Fumero in Italy’s Piedmont region to advance collaboration between our life science ecosystems. This partnership supports innovation, funding opportunities, technology exchange and global engagement for our members.
0
2
2
New funding alert: @ARPA_H's BioStabilization Systems (BoSS) program aims to make room temperature biologics possible by pioneering new technologies to produce, store and ship cells at room temperature, without any need for refrigeration. Learn more: https://t.co/bQf4OGZ1C3
0
0
0
Life-saving science relies on a dependable gas supply, and our member WestAir is a key partner. Their liquid nitrogen supports the San Diego Zoo’s cryopreservation work, protecting the genetic material of endangered species and biodiversity. Learn more: https://t.co/KjenqvaraF
0
0
0
Seeing the limits of slow, costly drug development, @AurekaBio built an agentic design platform that generates data 1,000x faster and scales discovery across multiple programs. Discover their journey and what's next in our member spotlight:
biocom.org
When Dr. Weian Zhao looked at the traditional drug development process, he saw a system plagued by inefficiency—one that could take 10 to 15 years and billions of dollars to deliver a single therapy....
0
0
0
In this month's Regulatory & Reimbursement Newsletter: our comments on the FDA analgesics draft guidance document, longtime FDA oncology leader now directing CDER, FDA operations resume and more. Read it here: https://t.co/snLZLxcrZC
0
0
0
🧬 2T Labs specializes in custom ELISA and PCR assay development for biotech and pharma. 💉Axent Biosciences creates next-generation stem cell therapies using engineered biomaterials. 💻 The Bioforge applies AI to speed up media and process optimization for biotech teams.
0
0
0
Happy #NewMemberMonday! 🌱 @botanicalsol delivers scalable botanical products for agriculture and pharma. 💼 @incub8coalition champions IP protection and VC-driven innovation to benefit patients. 🔬 @SanfordCRM drives stem cell research to develop cures for human disease.
1
0
0
Catalyst Awardee Alexander Titus, Ph.D., vice president of artificial intelligence (AI) and machine learning (ML) @aviditybio, uses AI and ML to accelerate therapies for rare diseases. Read his story: https://t.co/zc37LCNdIP
#BiocomCatalystAwards
0
0
0
In this week’s Bay Area Newsletter: @CytekBio named TIME Growth Leader; @EurekaThera solid tumor CAR T update; @metagenomi MGX-001 hemophilia A data; @OmniAbTech new antibody discovery deal; @visbymedical at-home FDA-authorized PCR STI test. Subscribe: https://t.co/mdZl9kL0jL
0
0
0
This Thanksgiving, we're grateful for the scientists, founders, educators and partners moving our industry forward every day. Thank you for the breakthroughs that create a brighter, healthier future for all.
0
0
0
In this month’s Core Newsletter: @G2Gconsulting is now offering non-dilutive funding support to our members, @SharpBusinessUS shares how to protect teams from AI-driven threats, @we_are_cultura unveils a sustainable workspace redesign, and more. Subscribe: https://t.co/B5wFKfDXU2
0
0
0
Catalyst Awardee Ananth Sridhar is leading the development of life-changing therapies for rare diseases at @BridgeBioPharma. Read his story: https://t.co/zc37LCNdIP
#BiocomCatalystAwards
0
0
0
Don’t miss our Member Appreciation Holiday Party & Catalyst Award Ceremony series held in San Diego, Greater LA and the Bay Area from December 2–4. Learn more: https://t.co/WsAivIiMAA
0
0
0
Congratulations to our member @SapientBio on launching its next-generation FFPE Proteomics platform, enabling large-scale protein measurement and multi-omic mapping from archived tissue samples. Learn more: https://t.co/CoKG1QF7K4
0
0
0
Catalyst Awardee Marco Lobba, Ph.D., CEO and founder of @CatenaBio, is advancing precision therapeutics for oncology and gene therapy through innovative molecular design. Read his story: https://t.co/1Jpsslf1v3
#BiocomCatalystAwards
0
0
0
In this week's Greater LA Newsletter: @AdagioMedical closed $19M; Armata opened a cGMP phage facility; @ArrowheadPharma signed a Novartis deal; @athostx + Xeptiva partnered on vaccine biomarkers; Pelage raised $120M; @the_lundquist received $9M. Subscribe: https://t.co/deUSvoyIny
0
0
0